These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6313539)

  • 21. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
    Lin MC; Wright DE; Hruby VJ; Rodbell M
    Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
    Hruby VJ
    Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
    Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
    J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological activities of catfish glucagon and glucagon-like peptide.
    Hoosein NM; Mahrenholz AM; Andrews PC; Gurd RS
    Biochem Biophys Res Commun; 1987 Feb; 143(1):87-92. PubMed ID: 3030323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic activity and conformational properties of glucagon and glucagon analogs.
    Epand RM; Cote TE; Hoa DH; Rosselin G; Schreier S
    Metabolism; 1976 Nov; 25(11 Suppl 1):1317-8. PubMed ID: 185490
    [No Abstract]   [Full Text] [Related]  

  • 28. Coupling of the glucagon receptor to adenylate cyclase.
    Houslay MD
    Biochem Soc Trans; 1979 Oct; 7(5):843-6. PubMed ID: 229036
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of an essential serine residue in glucagon: implication for an active site triad.
    Unson CG; Merrifield RB
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):454-8. PubMed ID: 8290548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
    Krstenansky JL; Trivedi D; Hruby VJ
    Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.
    Lipson KE; Kolhatkar AA; Cherksey BD; Donner DB
    Biochemistry; 1986 May; 25(9):2612-20. PubMed ID: 3013309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
    Epand RM; Epand RF; Stafford AR; Orlowski RC
    J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New glucagon analogues with conformational restrictions and altered amphiphilicity: effects on binding, adenylate cyclase and glycogenolytic activities.
    Hruby VJ; Gysin B; Trivedi D; Johnson DG
    Life Sci; 1993; 52(10):845-55. PubMed ID: 8445980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation of predicted structure to observed conformation and activity of glucagon analogs containing replacements at positions 19, 22, and 23.
    Murphy J; Zhang WJ; Macaulay W; Fasman G; Merrifield RB
    J Biol Chem; 1987 Dec; 262(36):17304-12. PubMed ID: 3693354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
    England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
    Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region.
    Iyengar R; Herberg JT
    J Biol Chem; 1984 Apr; 259(8):5222-9. PubMed ID: 6325424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model.
    Houslay MD; Ellory JC; Smith GA; Hesketh TR; Stein JM; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1977 Jun; 467(2):208-19. PubMed ID: 195604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.